A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy

PURPOSE: We report the toxicity and biochemical tumor control outcome of a prospective Phase II study using high-dose-rate brachytherapy (HDR) alone as a salvage therapy for recurrent disease after external beam radiotherapy (EBRT). METHODS: Forty-two patients with biopsy-proven recurrence were enro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Brachytherapy
Auteurs principaux: Yamada, Yoshiya, Kollmeier, Marisa A., Pei, Xin, Kan, Chu Cheng, Cohen, Gil’ad N., Donat, Sherri M., Cox, Brett W., Zelefsky, Michael J.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718052/
https://ncbi.nlm.nih.gov/pubmed/24373762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brachy.2013.11.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires